AZTA
Price
$30.47
Change
-$0.12 (-0.39%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
1.4B
61 days until earnings call
NEO
Price
$8.11
Change
+$0.11 (+1.38%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
1.03B
54 days until earnings call
Interact to see
Advertisement

AZTA vs NEO

Header iconAZTA vs NEO Comparison
Open Charts AZTA vs NEOBanner chart's image
Azenta
Price$30.47
Change-$0.12 (-0.39%)
Volume$11.14K
Capitalization1.4B
NeoGenomics
Price$8.11
Change+$0.11 (+1.38%)
Volume$61.63K
Capitalization1.03B
AZTA vs NEO Comparison Chart in %
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. NEO commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and NEO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (AZTA: $30.46 vs. NEO: $8.11)
Brand notoriety: AZTA and NEO are both not notable
AZTA represents the Pharmaceuticals: Other, while NEO is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 117% vs. NEO: 141%
Market capitalization -- AZTA: $1.4B vs. NEO: $1.03B
AZTA [@Pharmaceuticals: Other] is valued at $1.4B. NEO’s [@Medical Specialties] market capitalization is $1.03B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $155.76B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.03B. The average market capitalization across the [@Medical Specialties] industry is $10.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, both AZTA and NEO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 4 TA indicator(s) are bullish while NEO’s TA Score has 4 bullish TA indicator(s).

  • AZTA’s TA Score: 4 bullish, 3 bearish.
  • NEO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than NEO.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а +4.03% price change this week, while NEO (@Medical Specialties) price change was +8.42% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.82%. For the same industry, the average monthly price growth was +1.66%, and the average quarterly price growth was +6.20%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.80%. For the same industry, the average monthly price growth was +2.74%, and the average quarterly price growth was +15.83%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 18, 2025.

NEO is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.82% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+1.80% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($1.4B) has a higher market cap than NEO($1.03B). AZTA YTD gains are higher at: -39.080 vs. NEO (-50.789). AZTA has higher annual earnings (EBITDA): 11.3M vs. NEO (-28.47M). AZTA has more cash in the bank: 319M vs. NEO (164M). AZTA has less debt than NEO: AZTA (52.6M) vs NEO (412M). NEO (689M) and AZTA (669M) have equivalent revenues.
AZTANEOAZTA / NEO
Capitalization1.4B1.03B136%
EBITDA11.3M-28.47M-40%
Gain YTD-39.080-50.78977%
P/E RatioN/AN/A-
Revenue669M689M97%
Total Cash319M164M195%
Total Debt52.6M412M13%
FUNDAMENTALS RATINGS
AZTA vs NEO: Fundamental Ratings
AZTA
NEO
OUTLOOK RATING
1..100
6275
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9595
PRICE GROWTH RATING
1..100
6350
P/E GROWTH RATING
1..100
50100
SEASONALITY SCORE
1..100
5048

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (63) in the Medical Or Nursing Services industry is in the same range as AZTA (70) in the Electronic Production Equipment industry. This means that NEO’s stock grew similarly to AZTA’s over the last 12 months.

NEO's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as AZTA (100) in the Electronic Production Equipment industry. This means that NEO’s stock grew similarly to AZTA’s over the last 12 months.

NEO's SMR Rating (95) in the Medical Or Nursing Services industry is in the same range as AZTA (95) in the Electronic Production Equipment industry. This means that NEO’s stock grew similarly to AZTA’s over the last 12 months.

NEO's Price Growth Rating (50) in the Medical Or Nursing Services industry is in the same range as AZTA (63) in the Electronic Production Equipment industry. This means that NEO’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's P/E Growth Rating (50) in the Electronic Production Equipment industry is somewhat better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that AZTA’s stock grew somewhat faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTANEO
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OTCFX59.51N/A
N/A
T. Rowe Price Small-Cap Stock
RSPYX31.52N/A
N/A
Victory RS Partners Y
TMITX11.53N/A
N/A
Transamerica Mid Cap Growth I3
NWAYX14.30N/A
N/A
Nationwide GQG US Quality Eq Eagle
JAAGX81.80-0.25
-0.30%
Janus Henderson VIT Enterprise Instl